FDA’s Banner Year for Drug Approvals: Time to Change the Focus
By
Michael McCaughan / Email the Author / The RPM Report January 2012, Vol. 8, No. 2
Feature Articles / Word Count: 1689 / Article # 2012500014
Executive Summary
FDA is entering a big legislative year with a good story to tell based on 30 new molecular entity approvals. But the level of submissions remains constant—suggesting it may be time to shift the focus from what comes out of FDA to what makes it in.
$85.00
Buy Now
For $85.00, purchase this 1689-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.